No Data
No Data
Express News | GF SEC raised its rating on Guangdong Wanmei Biotechnology Co., Ltd. to Buy.
Marubi Biological (603983): The symbol investment Moyang Biological's hydroxyapatite products have been certified in Mexico.
Key point: Event: The company's investment fund, Qingdao Maoda, holds a 9.6% stake in Moyang Biotech. Moyang Biotech's high-end medical beauty product 'Youfu Lan Hydroxyethyl Phosphate Calcium Microsphere Facial Filler' has received the highest risk rating from Mexico's COFEPRIS.
Research Reports: Guosen maintains the "Outperform Market" rating for Marnie Bio, with multi-brand iterations supporting long-term growth.
The Guosen Research Reports indicate that Marubi Biotechnology (603983.SH) has undergone more than three years of adjustments and transformations, and has now revitalized its established domestic beauty brand. The main brand Marubi relies on the company's long-term research and development in the eye cream and restructured collagen sectors, and has successfully transformed through online channels, leveraging Technology and emotional marketing to deeply reach young consumers. It has successfully created two major series of products, the Little Red Pen and the Little Gold Needle, and is currently in a phase of product momentum explosion. Meanwhile, the emerging base makeup brand Lianhuo tightly grasps consumer pain points in base makeup, achieving breakthroughs through content marketing and top influencers, while continuously upgrading core products and extending into new categories.
Marubi Bio (603983): The L product series is in a period of explosive growth, with multi-brand iterations supporting long-term growth.
Item: Marubi Bio Co., as a well-established domestic beauty brand, has a development history of 22 years. Currently, it owns the main brand Marubi (founded in 2002) for mid-to-high-end anti-aging eye products, and the emerging makeup brand Lianhuo, focusing on base makeup products.
GTJA: WeChat mini-stores "gifting" open new scenarios, with snacks and beauty products expected to benefit.
Referring to the rapid popularization of WeChat Pay after the introduction of WeChat red envelopes, the gifting function is expected to help open a new traffic entrance for the WeChat e-commerce system and assist in user conversion.
Express News | Fangzheng Securities: Maintains a "Strong Buy" rating for Marubi Biotechnology, continuing to advance its layout in the medical aesthetics Sector.